SymbolAB
NameALLIANCEBERNSTEIN HOLDING L.P.
SectorFINANCE
RegionNorth America
IndustryInvestment Managers
Address501 COMMERCE STREET, NASHVILLE, Tennessee, 37203, United States
Telephone+1 615 622-0000
Fax
Email
Websitehttps://www.alliancebernstein.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK
Description

AllianceBernstein provides investment management services to institutional (45% of assets under management), retail (39%), and private (16%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of June 2022, AB had $647.0 billion in managed assets, composed primarily of fixed-income (41% of AUM) and equity (43%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder. The company also provides sell-side research and brokerage services through its Sanford Bernstein subsidiary.

Additional info from NASDAQ:
AllianceBernstein provides investment management services to institutional (45% of assets under management), retail (39%), and private (16%) clients through products that includes mutual funds, hedge funds, and separately managed accounts. At the end of June 2022, AB had $647.0 billion in managed assets, composed primarily of fixed-income (41% of AUM) and equity (43%) strategies, with other investments (made up of asset allocation services and certain other alternative investments) accounting for the remainder. The company also provides sell-side research and brokerage services through its Sanford Bernstein subsidiary.

2026-04-20 19:32

AB Science: New publication on medrxiv demonstrating substantial survival benefits and preserved quality of life with masitinib in ALS patients

Read more
2026-04-20 19:32

AB Science : Nouvelle publication sur medrxiv démontrant des bénéfices substantiels en termes de survie et de qualité de vie préservée avec le masitinib chez les patients atteints de SLA

Read more
2026-04-16 17:20

AB Science provides an update on its clinical development program.

Read more
2026-04-16 17:20

AB Science fait le point sur son programme de développement clinique

Read more
2026-04-13 20:50

(99% Neutral) ALLIANCEBERNSTEIN HOLDING L.P. (AB) Announces Regulatory Update

Read more
2026-04-13 20:05

AB Announces March 31, 2026 Assets Under Management

Read more
2026-04-06 20:05

AB to Report First Quarter 2026 Results on April 28, 2026

Read more
2026-03-11 20:05

AB Announces February 28, 2026 Assets Under Management

Read more